Relafen 750, the advanced preparation of naproxen, represents a intriguing example from the biochemical pharmacy view. The mechanism of action, primarily involving blocking of cyclooxygenase enzymes and COX-1 and COX-2 – leads to significant lowering in prostaglandin production. Within a biochemi